FEATURED ARTICLES
Why More Biotechs Are Starting Trials In Australia
Why are so many U.S. biotechs heading to Australia for their first-in-human trials? Speed, cost, and simplicity. In our latest piece, Megan Robertson and Tina Soulis break down how sponsors can move from protocol to first patient in just a few months—while saving money and generating data regulators will accept worldwide.
-
![IMG_2309_QeVonte]( "Age Restrictions In Clinical Trials Unjustly Harm Adults With Childhood Cancer")
Age Restrictions In Clinical Trials Unjustly Harm Adults With Childhood CancerHow old is too old for a pediatric cancer trial? Mom-turned-patient advocate Rosemary Sherrod argues that too-stringent age criteria wrongly exclude pediatric cancer patients as they approach adulthood.
-
![Teenager blood test-GettyImages-1780575106]( "From Protocol To People: Teva's Patient-First Clinical Trials Approach")
From Protocol To People: Teva's Patient-First Clinical Trials ApproachTeva Pharmaceuticals' Head of Global Early Clinical Development Eran Harary, MD, shares how the company approaches drug development by getting patient input early and often.
-
![Healthy gut, food-GettyImages-1301830934]( "2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets")
2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination DietsVibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.
SERVICES & PRODUCTS
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC Services
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
Experience customized and validated flow cytometry (FCM) biomarkers and panels for your clinical research on a global scale. Learn how FCM can enhance your research and help develop the panels you need.
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.